Karen Ferrante
Direttore/Membro del Consiglio presso MACROGENICS, INC.
Patrimonio netto: 63 521 $ in data 31/05/2024
Posizioni attive di Karen Ferrante
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MACROGENICS, INC. | Direttore/Membro del Consiglio | 25/01/2017 | - |
| Independent Dir/Board Member | 25/01/2017 | - | |
| COGENT BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/02/2018 | - |
| Independent Dir/Board Member | 01/02/2018 | - | |
New England Women In Science Executives Club
 New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services The New England Women In Science Executives Club is a women's club that provides a platform for members to discuss their challenges, solutions, and ideas. The private company is based in Framingham, MA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Karen Ferrante
Precedenti posizioni note di Karen Ferrante
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HUTCHMED (CHINA) LIMITED | Direttore/Membro del Consiglio | 01/02/2017 | 12/05/2023 |
| Independent Dir/Board Member | 01/02/2017 | 12/05/2023 | |
| PROGENICS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 29/01/2014 | 19/06/2020 |
| Independent Dir/Board Member | 29/01/2014 | 19/06/2020 | |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Direttore Tecnico/Scientifico/R&S | 24/04/2014 | 31/08/2016 |
| BAXALTA INC | Direttore/Membro del Consiglio | 27/07/2015 | 03/06/2016 |
| Independent Dir/Board Member | 27/07/2015 | 03/06/2016 | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/09/2007 | 01/07/2013 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/09/2007 | 01/07/2013 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Karen Ferrante
| Providence College | Undergraduate Degree |
| Georgetown University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 13 |
| Hong Kong | 2 |
| Giappone | 2 |
Posizioni
| Director/Board Member | 6 |
| Corporate Officer/Principal | 5 |
| Independent Dir/Board Member | 5 |
Settori
| Health Technology | 12 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| COGENT BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| MACROGENICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
New England Women In Science Executives Club
New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services The New England Women In Science Executives Club is a women's club that provides a platform for members to discuss their challenges, solutions, and ideas. The private company is based in Framingham, MA. | Commercial Services |
- Borsa valori
- Insiders
- Karen Ferrante
- Esperienza
